Insmed (INSM) Revenue (2010 - 2026)

Insmed's Revenue history runs 12 years deep, the most recent figure standing at $306.0 million for Q1 2026.

• In Q1 2026, Revenue rose 229.62% year-over-year to $306.0 million; the TTM figure through Mar 2026 stood at $819.6 million (up 115.09% YoY), while the FY2025 annual figure was $606.4 million, up 66.73% from the prior year.
• Revenue was $306.0 million for Q1 2026 at Insmed, up from $263.8 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $306.0 million in Q1 2026 to a low of $53.1 million in Q1 2022.
• Historically, Revenue has averaged $107.5 million across 5 years, with a median of $83.7 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Revenue rose 5.66% in 2022, then soared 229.62% in 2026.
• A 5-year view of Revenue shows it stood at $59.3 million in 2022, then soared by 41.13% to $83.7 million in 2023, then climbed by 24.79% to $104.4 million in 2024, then surged by 152.62% to $263.8 million in 2025, then increased by 15.96% to $306.0 million in 2026.
• The last three Revenue figures came in at $306.0 million (Q1 2026), $263.8 million (Q4 2025), and $142.3 million (Q3 2025), per Business Quant data.